Back
Pharvaris NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
59
PHVS
Pharvaris NV
Last Price:
19.55
Seasonality Move:
-1.38%
Sell
25
PRQR
ProQR Therapeutics NV
Last Price:
1.72
Seasonality Move:
-1.1%
Buy
59
Pharvaris NV (PHVS)
is a Buy
Is Pharvaris NV a Buy, Sell or Hold?
- The current Pharvaris NV [PHVS] share price is $19.38. The Score for PHVS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- PHVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.73. The Score for PRQR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHVS Stock Price Chart
What is Pharvaris NV's stock price today?
-
The Pharvaris NV share price today is $19.38
The current trend is moderately bearish and PHVS is experiencing selling pressure, which indicates risk of future bearish movement.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
PHVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.67 | Buy |
| Relative Strength Index (14 RSI): | 50.55 | Buy |
| Chaikin Money Flow: | -517011 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.84 - 20.4) | Buy |
| Bollinger Bands (100): | (16.93 - 20.71) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 30.02 | Sell |
| Chaikin Money Flow: | -51308 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.07) | Sell |
| Bollinger Bands (100): | (1.74 - 2.02) | Sell |
PHVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.49 | Sell |
| 20-day SMA: | 19.34 | Buy |
| 50-day SMA: | 18.32 | Buy |
| 200-day SMA: | 22.14 | Sell |
| 8-day EMA: | 20.17 | Sell |
| 20-day EMA: | 19.56 | Sell |
| 50-day EMA: | 18.89 | Buy |
| 200-day EMA: | 19.69 | Sell |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Sell |
| 20-day SMA: | 1.9 | Sell |
| 50-day SMA: | 1.92 | Sell |
| 200-day SMA: | 1.99 | Sell |
| 8-day EMA: | 1.81 | Sell |
| 20-day EMA: | 1.87 | Sell |
| 50-day EMA: | 1.9 | Sell |
| 200-day EMA: | 1.91 | Sell |
Pharvaris NV Earnings Growth & PHVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.52 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharvaris NV Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||